Laurel Wealth Advisors (California)’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-18,238
Closed -$628K 395
2020
Q2
$628K Sell
18,238
-898
-5% -$27.9K 0.12% 191
2020
Q1
$536K Sell
19,136
-3,445
-15% -$115K 0.12% 190
2019
Q4
$784K Sell
22,581
-2,686
-11% -$90.9K 0.13% 184
2019
Q3
$815K Sell
25,267
-614
-2% -$21K 0.14% 174
2019
Q2
$887K Sell
25,881
-1,382
-5% -$46.6K 0.19% 136
2019
Q1
$914K Sell
27,263
-2,013
-7% -$63.4K 0.23% 121
2018
Q4
$808K Sell
29,276
-10
-0% -$310 0.24% 110
2018
Q3
$1.13M Buy
29,286
+241
+0.8% +$8.87K 0.28% 94
2018
Q2
$1.02M Buy
29,045
+1,241
+4% +$43.3K 0.27% 99
2018
Q1
$926K Buy
27,804
+3,439
+14% +$117K 0.29% 92
2017
Q4
$808K Buy
+24,365
New +$809K 0.23% 101

Other funds holding FFTY

Laurel Wealth Advisors (California)'s FFTY Position: Q3 2020 in Review

Laurel Wealth Advisors (California) sold out of CapForce IBD 50 ETF (FFTY) in Q3 2020, closing a stake of 18,238 shares — an estimated $628K sold.

Laurel Wealth Advisors (California) first reported a position in FFTY in Q4 2017 and held it in 11 quarters. The position peaked at $1.13M in Q3 2018. 61 funds tracked by Wall St. Rank hold FFTY as of Q3 2020.

  • Laurel Wealth Advisors (California) reported no remaining CapForce IBD 50 ETF position as of Q3 2020 after selling out during the quarter.
  • Laurel Wealth Advisors (California) sold 18,238 CapForce IBD 50 ETF shares in Q3 2020, an estimated $628K.
  • Laurel Wealth Advisors (California) first reported a position in CapForce IBD 50 ETF in Q4 2017 and held it in 11 quarters.
  • Laurel Wealth Advisors (California)'s CapForce IBD 50 ETF position peaked at $1.13M in Q3 2018.
  • 61 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q3 2020.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q3 2020, filed 13 Nov 2020.